Chlorahololide C is primarily investigated for its potential antifungal and antimicrobial properties. It shows activity against certain drug-resistant fungal strains, making it a candidate for development in pharmaceutical applications, particularly in treating topical or systemic fungal infections. Due to its complex macrocyclic structure, it may interfere with microbial cell membrane integrity or disrupt essential biosynthetic pathways in target organisms. Research is ongoing to evaluate its efficacy, toxicity profile, and possible structural modifications to enhance bioavailability and therapeutic index. Its natural origin from marine or microbial sources also supports its role in ecological chemical defense studies.